Designation: Co-Founder, Regulatory Consultant
Mr. Lucking is currently Vice President of Regulatory Affairs, Quality Assurance and Clinical Research at ProSolus Pharmaceuticals. He was Executive Director of Regulatory Affairs, QA & QC for Hercon Pharmaceuticals, LLC from 2012-13. Prior to co-founding ABP in 2003, Mr. Lucking held various executive positions with Noven Pharmaceuticals, Inc from 1987-2003.
His most recent position was as Executive Director of clinical Research and Regulatory Affairs. Mr. Lucking obtained approval for five transdermal products during his fifteen years at Noven. He was also responsible for conducting pre-clinical and clinical trials, interfacing with the FDA and European regulatory agencies and creating strategic plans relating to the development of new drugs. He was responsible for the filing of New Drug Applications with the FDA and Marketing Authorization Applications in Europe. From 1983 to 1987 Mr. Lucking was employed by Cordis Dow Corporation, a manufacturer of artificial kidneys. Mr. Lucking has a B.S degree in Biological Science from Florida State University. He has co-authored an article in the European Journal of Clinical Research.